CEO end of year message 2019
2019 has been another successful year for Cresset with significant growth and developments in both software and services. I want ...
Following excellent progress in this drug discovery project that we announced in March, I am delighted that our unique software, virtual screening capabilities and highly experienced team have contributed to Parkinson’s UK securing further funding for the novel gene transcription modulators collaboration we are working on along with Selcia.
We look forward to continuing to deliver molecular modeling support for the next phase of this important project.